100 related articles for article (PubMed ID: 23375624)
1. Differences in plasma prolactin levels in patients with schizophrenia treated on monotherapy with five second-generation antipsychotics.
Suzuki Y; Sugai T; Fukui N; Watanabe J; Ono S; Tsuneyama N; Saito M; Someya T
Schizophr Res; 2013 Apr; 145(1-3):116-9. PubMed ID: 23375624
[TBL] [Abstract][Full Text] [Related]
2. Sex differences in the effect of four second-generation antipsychotics on QTc interval in patients with schizophrenia.
Suzuki Y; Sugai T; Fukui N; Watanabe J; Ono S; Tsuneyama N; Saito M; Someya T
Hum Psychopharmacol; 2013 May; 28(3):215-9. PubMed ID: 23553637
[TBL] [Abstract][Full Text] [Related]
3. Dose-dependent effects of olanzapine on QT intervals and plasma prolactin levels in Japanese patients with stable schizophrenia.
Suzuki Y; Ono S; Sugai T; Fukui N; Watanabe J; Tsuneyama N; Sawamura K; Someya T
Hum Psychopharmacol; 2011 Aug; 26(6):440-3. PubMed ID: 21823168
[TBL] [Abstract][Full Text] [Related]
4. Risk factors of hyperprolactinemia induced by risperidone and olanzapine and their correlations with plasma glucose and lipids.
He S; Yu WJ; Wang X; Zhang L; Zhao N; Li G; Shen YF; Li H
Gen Psychiatr; 2020; 33(4):e100206. PubMed ID: 32695960
[TBL] [Abstract][Full Text] [Related]
5. Lower Prolactin Levels in Patients Treated With Aripiprazole Regardless of Antipsychotic Monopharmacy or Polypharmacy.
Sugai T; Suzuki Y; Yamazaki M; Sugawara N; Yasui-Furukori N; Shimoda K; Mori T; Ozeki Y; Matsuda H; Okamoto K; Sagae T; Someya T
J Clin Psychopharmacol; 2020; 40(1):14-17. PubMed ID: 31834097
[TBL] [Abstract][Full Text] [Related]
6. The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review.
Peuskens J; Pani L; Detraux J; De Hert M
CNS Drugs; 2014 May; 28(5):421-53. PubMed ID: 24677189
[TBL] [Abstract][Full Text] [Related]
7. Changes in QT interval after switching to quetiapine in Japanese patients with schizophrenia.
Suzuki Y; Sugai T; Fukui N; Watanabe J; Ono S; Tsuneyama N; Saito M; Someya T
Hum Psychopharmacol; 2013 Jan; 28(1):94-6. PubMed ID: 23161621
[TBL] [Abstract][Full Text] [Related]
8. Optimal Dosing of Risperidone and Olanzapine in the Maintenance Treatment for Patients With Schizophrenia and Related Psychotic Disorders: A Retrospective Multicenter Study.
Yoshimura Y; Takeda T; Kishi Y; Harada T; Nomura A; Washida K; Yoshimura B; Sato K; Yada Y; Aoki S
J Clin Psychopharmacol; 2017 Jun; 37(3):296-301. PubMed ID: 28306616
[TBL] [Abstract][Full Text] [Related]
9. Effects of olanzapine on resting heart rate in Japanese patients with schizophrenia.
Tajiri M; Suzuki Y; Sugai T; Tsuneyama N; Someya T
PLoS One; 2018; 13(7):e0199922. PubMed ID: 30016331
[TBL] [Abstract][Full Text] [Related]
10. Integrating machine learning with electronic health record data to facilitate detection of prolactin level and pharmacovigilance signals in olanzapine-treated patients.
Zhu X; Hu J; Xiao T; Huang S; Shang D; Wen Y
Front Endocrinol (Lausanne); 2022; 13():1011492. PubMed ID: 36313772
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: comprehensive review of prospective head-to-head and placebo-controlled comparisons.
Fraguas D; Correll CU; Merchán-Naranjo J; Rapado-Castro M; Parellada M; Moreno C; Arango C
Eur Neuropsychopharmacol; 2011 Aug; 21(8):621-45. PubMed ID: 20702068
[TBL] [Abstract][Full Text] [Related]
12. Adjunctive aripiprazole in the treatment of risperidone-induced hyperprolactinemia: A randomized, double-blind, placebo-controlled, dose-response study.
Chen JX; Su YA; Bian QT; Wei LH; Zhang RZ; Liu YH; Correll C; Soares JC; Yang FD; Wang SL; Zhang XY
Psychoneuroendocrinology; 2015 Aug; 58():130-40. PubMed ID: 25981348
[TBL] [Abstract][Full Text] [Related]
13. Risperidone oral solution versus standard tablets for the acute treatment of patients with schizophrenia.
Kusumi I; Honda M; Ito K; Uemura K; Kumazawa Y; Ishikane T; Niide Y; Koyama T
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):537-40. PubMed ID: 21168464
[TBL] [Abstract][Full Text] [Related]
14. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
Khaldi S; Kornreich C; Choubani Z; Gourevitch R
Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of second-generation antipsychotics with acute-phase schizophrenia.
Hatta K; Sato K; Hamakawa H; Takebayashi H; Kimura N; Ochi S; Sudo Y; Asukai N; Nakamura H; Usui C; Kawabata T; Hirata T; Sawa Y
Schizophr Res; 2009 Aug; 113(1):49-55. PubMed ID: 19553086
[TBL] [Abstract][Full Text] [Related]
16. Second-generation antipsychotics and adiponectin levels in schizophrenia: A comparative meta-analysis.
Bartoli F; Crocamo C; Clerici M; Carrà G
Eur Neuropsychopharmacol; 2015 Oct; 25(10):1767-74. PubMed ID: 26164075
[TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine tests during treatment with neuroleptic drugs: I. Plasma prolactin response to chlorpromazine challenge.
Kolakowska T; Fraser S; Franklin M; Knox J
Psychopharmacology (Berl); 1981; 72(3):283-5. PubMed ID: 6111824
[TBL] [Abstract][Full Text] [Related]
18. The effect of smoking status on the plasma concentration of prolactin already elevated by risperidone treatment in schizophrenia patients.
Ohta C; Yasui-Furukori N; Furukori H; Tsuchimine S; Saito M; Nakagami T; Yoshizawa K; Kaneko S
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):573-6. PubMed ID: 21216266
[TBL] [Abstract][Full Text] [Related]
19. Gender differences in the relationship between the risperidone metabolism and the plasma prolactin levels in psychiatric patients.
Suzuki Y; Fukui N; Watanabe J; Ono S; Sugai T; Tsuneyama N; Inoue Y; Someya T
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1266-8. PubMed ID: 20621147
[TBL] [Abstract][Full Text] [Related]
20. Time course of the changes in antipsychotic-induced hyperprolactinemia following the switch to aripiprazole.
Lu ML; Shen WW; Chen CH
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1978-81. PubMed ID: 18848860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
